Literature DB >> 2817598

Home dampness and respiratory morbidity in children.

B Brunekreef1, D W Dockery, F E Speizer, J H Ware, J D Spengler, B G Ferris.   

Abstract

This study examined the relationship between measures of home dampness and respiratory illness and symptoms in a cohort of 4,625 eight- to 12-yr-old children living in six U.S. cities. Home dampness was characterized from questionnaire reports of mold or mildew inside the home, water damage to the home, and the occurrence of water on the basement floor. Symptoms of respiratory and other illness were collected by questionnaire. Pulmonary function was measured by spirometry. Signs of home dampness were reported in a large proportion of the homes. In five of the six cities, one or more of the dampness indicators were reported in more than 50% of the homes. The association between measures of home dampness and both respiratory symptoms and other non-chest illness was both strong and consistent. Odds ratios for molds varied from 1.27 to 2.12, and for dampness from 1.23 to 2.16 after adjustment for maternal smoking, age, gender, city of residence, and parental education. The relationship between home dampness and pulmonary function was weak, with an estimated mean reduction of 1.0% in FEF25-75 associated with dampness and 1.6% with molds. We conclude that dampness in the home is common in many areas of the United States and that home dampness is a strong predictor of symptoms of respiratory and other illness symptoms among 8- to 12-yr-old children.

Entities:  

Mesh:

Year:  1989        PMID: 2817598     DOI: 10.1164/ajrccm/140.5.1363

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  63 in total

Review 1.  Socioeconomic status and chronic obstructive pulmonary disease.

Authors:  E Prescott; J Vestbo
Journal:  Thorax       Date:  1999-08       Impact factor: 9.139

Review 2.  Housing and health--current issues and implications for research and programs.

Authors:  T D Matte; D E Jacobs
Journal:  J Urban Health       Date:  2000-03       Impact factor: 3.671

3.  Testing the association between residential fungus and health using ergosterol measures and cough recordings.

Authors:  R E Dales; D Miller; J White
Journal:  Mycopathologia       Date:  1999       Impact factor: 2.574

Review 4.  Housing and health: time again for public health action.

Authors:  James Krieger; Donna L Higgins
Journal:  Am J Public Health       Date:  2002-05       Impact factor: 9.308

5.  Prevalence of asthma and respiratory symptoms in south-central Durban, South Africa.

Authors:  J Nriagu; T Robins; L Gary; G Liggans; R Davila; K Supuwood; C Harvey; C C Jinabhai; R Naidoo
Journal:  Eur J Epidemiol       Date:  1999-09       Impact factor: 8.082

6.  Improving the health of workers in indoor environments: priority research needs for a national occupational research agenda.

Authors:  Mark J Mendell; William J Fisk; Kathleen Kreiss; Hal Levin; Darryl Alexander; William S Cain; John R Girman; Cynthia J Hines; Paul A Jensen; Donald K Milton; Larry P Rexroat; Kenneth M Wallingford
Journal:  Am J Public Health       Date:  2002-09       Impact factor: 9.308

Review 7.  Environmental control for fungal allergen exposure.

Authors:  Peyton A Eggleston
Journal:  Curr Allergy Asthma Rep       Date:  2003-09       Impact factor: 4.806

8.  Examination of fungi in domestic interiors by using factor analysis: correlations and associations with home factors.

Authors:  H J Su; A Rotnitzky; H A Burge; J D Spengler
Journal:  Appl Environ Microbiol       Date:  1992-01       Impact factor: 4.792

9.  Housing standards: a glossary of housing and health.

Authors:  P Howden-Chapman
Journal:  J Epidemiol Community Health       Date:  2004-03       Impact factor: 3.710

10.  Mould/dampness exposure at home is associated with respiratory disorders in Italian children and adolescents: the SIDRIA-2 Study.

Authors:  M Simoni; E Lombardi; G Berti; F Rusconi; S La Grutta; S Piffer; M G Petronio; C Galassi; F Forastiere; G Viegi
Journal:  Occup Environ Med       Date:  2005-09       Impact factor: 4.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.